TABLE 8.
Clonea
|
HIV p24 (pg/ml)b
|
||||
---|---|---|---|---|---|
No. | Name | SF162 | US657 | US714 | US727 |
1 | H1.20 | 300 ± 0.3 | 12,500 ± 1.3 | 15,200 ± 1.5 | 22,000 ± 2.3 |
2 | H1.25 | 0 | 21,500 ± 1.7 | 29,700 ± 2.3 | 27,000 ± 3.3 |
3 | H1.15 | 550 ± 0.5 | 420 ± 0.5 | 1,300 ± 1.0 | 600 ± 0.5 |
4 | H2.10 | 2,100 ± 1.3 | 18,500 ± 1.7 | 21,000 ± 3.0 | 23,000 ± 2.7 |
5 | H2.33 | 0 | 1,700 ± 0.7 | 2,200 ± 1.5 | 950 ± 0.3 |
6 | H2.5 | 2,500 ± 1.3 | 23,000 ± 2.7 | 17,000 ± 1.7 | 34,500 ± 3.3 |
T-cell clones were generated, maintained, and activated as described in Materials and Methods.
Clones were infected with the indicated viral isolates as described in Materials and Methods. At day 7, cell-free supernatants were used for HIV p24 assays (SEM [103] for triplicates of two experiments).